Ki-67 and minichromosome maintenance-7 (MCM7) expression in canine pituitary corticotroph adenomas

Domestic Animal Endocrinology

Volumn 41, Issue 4, 2011, Pages 207-213

  Ishino, H ^a   Hara, Y ^a   Takekoshi, S ^b   Teshima, T ^a   Teramoto, A ^c   Osamura, R Y ^b   Tagawa, M ^a  

^a NIPPON VETERINARY AND LIFE SCIENCE UNIVERSITY   (Japan)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Corticotroph adenoma; Dog; Minichromosome maintenance protein; Pituitary; Proliferation marker

Indexed keywords

CELL CYCLE PROTEIN; DNA BINDING PROTEIN; KI 67 ANTIGEN; NUCLEAR PROTEIN;

ACTH SECRETING ADENOMA; ADENOMA; ANIMAL; ANIMAL DISEASE; ARTICLE; DOG; DOG DISEASE; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; PHYSIOLOGY;

ACTH-SECRETING PITUITARY ADENOMA; ADENOMA; ANIMALS; CELL CYCLE PROTEINS; DNA-BINDING PROTEINS; DOG DISEASES; DOGS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; KI-67 ANTIGEN; MALE; NUCLEAR PROTEINS;

CANIS FAMILIARIS;

EID: 80053592730     PISSN: 07397240     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.domaniend.2011.07.002     Document Type: Article

References (30)

1. Feldman E.C., Nelson R.W. Canine hyperadrenocorticism (Cushing's syndrome). Canine and Feline Endocrinology and Reproduction 2004, 252-357. WB Saunders Co, Philadelphia, PA. 3rd ed. E.C. Feldman, R.W. Nelson (Eds.).
2. Bertoy E.H., Feldman E.C., Nelson R.W., Dublin A.B., Reid M.H., Feldman M.S. One-year follow-up evaluation of magnetic resonance imaging of the brain in dogs with pituitary-dependent hyperadrenocorticism. J Am Vet Med Assoc 1996, 208:1268-1273.
3. Duesberg C.A., Feldman E.C., Nelson R.W., Bertoy E.H., Dublin A.B., Reid M.H. Magnetic resonance imaging for diagnosis of pituitary macrotumors in dogs. J Am Vet Med Assoc 1995, 206:657-662.
4. Wood F.D., Pollard R.E., Uerling M.R., Feldman E.C. Diagnostic imaging findings and endocrine test results in dogs with pituitary-dependent hyperadrenocorticism that did or did not have neurologic abnormalities: 157 cases (1989-2005). J Am Vet Med Assoc 2007, 231:1081-1085.
5. Kooistra H.S., Voorhout G., Mol J.A., Rijnberk A. Correlation between impairment of glucocorticoid feedback and the size of the pituitary gland in dogs with pituitary-dependent hyperadrenocorticism. J Endocrinol 1997, 152:387-394.
6. Hanson J.M., Teske E., Voorhout G., Galac S., Kooistra H.S., Meij B.P. Prognostic factors for outcome after transsphenoidal hypophysectomy in dogs with pituitary-dependent hyperadrenocorticism. J Neurosurg 2007, 107:830-840.
7. Gerdes J., Lemke H., Baisch H., Wacker H.H., Schwab U., Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody ki-67. J Immunol 1984, 133:1710-1715.
8. Brown D.C., Gatter K.C. Ki67 protein: the immaculate deception?. Histopathology 2002, 40:2-11.
9. Honegger J., Prettin C., Feuerhake F., Petrick M., Shulute-Monting J., Reincke M. Expression of ki-67 antigen in nonfunctioning pituitary adenomas: Correlation with growth velocity and invasiveness. J Neurosurg 2003, 99:674-679.
10. Losa M., Barzaghi R.L., Mortini P., et al. Determination of the proliferation and apoptotic index in adrenocorticotropin-secreting pituitary tumors: comparison between micro- and macroadenomas. Am J Pathol 2000, 156:245-251.
11. Mastronardi A.L., Guiducci A., Puzzilli F. Lack of correlation between ki-67 labeling index and tumor size of anterior pituitary adenomas. BMC Cancer 2001, 1:12.
12. Salehi F., Agur A., Scheithauer B.W., Kovacs K., Lloyd R.V., Cusimano M. Ki-67 in pituitary neoplasms: a review-part I. Neurosurgery 2009, 65:429-437.
13. Giaginis C., Vgenopoulou S., Vielh P., Theocharis S. MCM proteins as diagnostic and prognostic tumor markers in the clinical setting. Histol Histopathol 2010, 25:351-370.
14. Tachibana K.K., Gonzalez M.A., Coleman N. Cell-cycle dependent regulation of DNA replication and its relevance to cancer pathology. J Pathol 2005, 205:123-129.
15. Freeman A., Morris L.S., Mills A.D., et al. Minichromosome maintenance proteins as biological markers of dysplasia and malignancy. Clin Cancer Res 1999, 5:2121-2132.
16. Ha S.A., Shin S.M., Namkoong H., et al. Cancer-associated expression of minichromosome maintenance 3 gene in several human cancers and its involvement in tumorigenesis. Clin Cancer Res 2004, 10:8386-8395.
17. Dallago C.M., Barbosa-Coutinho L.M., Ferreira N.P., Meurer R., Pereira-Lima J.F., Oliveira Mda C. Determination of cell proliferation using Mcm2 antigen and evaluation of apoptosis and TGF-beta1 expression in GH-secreting or clinically nonfunctioning pituitary adenomas. Endocr Pathol 2010, 21:32-39.
18. van Rijn S.J., Grinwis G.C., Penning L.C., Meij B.P. Expression of Ki-67, PCNA, and p27kip1 in canine pituitary corticotroph adenomas. Domest Anim Endocrinol 2010, 38:244-252.
19. Meij B.P., Voorhout G., van den Ingh T.S., Hazewinkel H.A., Teske E., Rijnberk A. Results of transsphenoidal hypophysectomy in 52 dogs with pituitary-dependent hyperadrenocorticism. Vet Surg 1998, 27:246-261.
20. Meij B.P., Voorhout G., Van den Ingh T.S., Hazewinkel H.A., Van't Verlaat J.W. Transsphenoidal hypophysectomy in beagle dogs: evaluation of a microsurgical technique. Vet Surg 1997, 26:295-309.
21. Taoda T., Hara Y., Takekoshi S., et al. Effect of mitotane on pituitary corticotrophs in clinically normal dogs. Am J Vet Res 2006, 67:1385-1394.
22. Schotanus B.A., van den Ingh T.S., Penning L.C., Rothuizen J., Roskams T.A., Spee B. Cross-species immunohistochemical investigation of the activation of the liver progenitor cell niche in different types of liver disease. Liver Int 2009, 29:1241-1252.
23. Com E., Rolland A.D., Guerrois M., et al. Identification, molecular cloning, and cellular distribution of the rat homolog of minichromosome maintenance protein 7 (MCM7) in the rat testis. Mol Reprod Dev 2006, 73:866-877.
24. Kontogeorgos G. Predictive markers of pituitary adenoma behavior. Neuroendocrinology 2006, 83:179-188.
25. Katznelson L., Bogan J.S., Trob J.R., et al. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas. J Clin Endocrinol Metab 1998, 83:1619-1623.
26. Mengel M., von Wasielewski R., Wiese B., Rüdiger T., Müller-Hermelink H.K., Kreipe H. Inter-laboratory and inter-observer reproducibility of immunohistochemical assessment of the Ki-67 labelling index in a large multi-centre trial. J Pathol 2002, 198:292-299.
27. MacCallum D.E., Hall P.A. The location of pKi67 in the outer dense fibrillary compartment of the nucleolus points to a role in ribosome biogenesis during the cell division cycle. J Pathol 2000, 190:537-544.
28. Maiorano D., Lutzmann M., Merchali M. MCM proteins and DNA replication. Curr Opin Cell Biol 2006, 18:130-136.
29. Stoeber K., Tlsty T.D., Happerfield L., et al. DNA replication licensing and human cell proliferation. J Cell Sci 2001, 114:2027-2041.
30. Shibuya M., Saito F., Miwa T., Davis R.L., Wilson C.B., Hoshino T. Histochemical study of pituitary adenomas with Ki-67 and anti-DNA polymerase alpha monoclonal antibodies, bromodeoxyuridine labeling, and nucleolar organizer region counts. Acta Neuropathol 1992, 84:178-183.